Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 20 550 KRW -1.44%
Market Cap: 302.3B KRW
Have any thoughts about
Korea United Pharm Inc?
Write Note

Korea United Pharm Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Korea United Pharm Inc
Interest Income Expense Peer Comparison

Comparables:
000100
326030
008930
128940
S
000250

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Korea United Pharm Inc
KRX:033270
Interest Income Expense
â‚©12.1B
CAGR 3-Years
N/A
CAGR 5-Years
26%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Interest Income Expense
â‚©65.9B
CAGR 3-Years
-3%
CAGR 5-Years
6%
CAGR 10-Years
0%
SK Biopharmaceuticals Co Ltd
KRX:326030
Interest Income Expense
-â‚©11.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Interest Income Expense
â‚©70.8B
CAGR 3-Years
93%
CAGR 5-Years
36%
CAGR 10-Years
35%
Hanmi Pharm Co Ltd
KRX:128940
Interest Income Expense
-â‚©15.4B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Interest Income Expense
-â‚©4.9B
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
N/A

See Also

What is Korea United Pharm Inc's Interest Income Expense?
Interest Income Expense
12.1B KRW

Based on the financial report for Jun 30, 2024, Korea United Pharm Inc's Interest Income Expense amounts to 12.1B KRW.

What is Korea United Pharm Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
26%

Over the last year, the Interest Income Expense growth was 95%.

Back to Top